Fig. 7. PLC activation contributes to GSDMD-mediated septic death.
(A) Analysis of animal survival in mice with or without repeated intraperitoneal administration of U73122 (30 mg/kg) at three, 24, 48, and 72 hours after CLP (22-gauge needle)-induced sepsis (n=10–20 mice/group; *, P<0.05, Kaplan-Meier survival analysis). Gpx4Mye−/− mice data was the same control as Fig. 1H (middle-grade sepsis). (B) In parallel, quantitation of serum CK, BUN, and ALT in middle grade septic mice at 72 hours (n=5–8 mice/group; *, P<0.05, ANOVA LSD test). Data are presented as median value (black line), interquartile range (box), and minimum and maximum of all data (black line).
